应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02162 康诺亚-B
已收盘 04-10 16:08:18
40.800
+2.100
+5.43%
最高
42.000
最低
39.200
成交量
187.35万
今开
39.200
昨收
38.700
日振幅
7.24%
总市值
114.13亿
流通市值
114.13亿
总股本
2.80亿
成交额
7,701万
换手率
0.67%
流通股本
2.80亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
康诺亚-B03月10日主力净流出652万元 散户资金买入
市场透视 · 03-10
康诺亚-B03月10日主力净流出652万元 散户资金买入
康诺亚-B盘中异动 下午盘股价大跌5.04%
市场透视 · 03-10
康诺亚-B盘中异动 下午盘股价大跌5.04%
康诺亚-B03月07日主力净流入136万元 散户资金抛售
市场透视 · 03-07
康诺亚-B03月07日主力净流入136万元 散户资金抛售
康诺亚-B03月04日主力净流入675万元 散户资金抛售
市场透视 · 03-04
康诺亚-B03月04日主力净流入675万元 散户资金抛售
康诺亚-B盘中异动 急速跳水5.10%
市场透视 · 02-28
康诺亚-B盘中异动 急速跳水5.10%
康诺亚-B盘中异动 下午盘股价大涨5.09%报37.150港元
市场透视 · 02-26
康诺亚-B盘中异动 下午盘股价大涨5.09%报37.150港元
康诺亚-B盘中异动 股价大跌5.02%报35.000港元
市场透视 · 02-25
康诺亚-B盘中异动 股价大跌5.02%报35.000港元
康诺亚半年内四次NewCo出海,董事长称“非割青苗而是要培养茁壮”
第一财经 · 02-19
康诺亚半年内四次NewCo出海,董事长称“非割青苗而是要培养茁壮”
中国内地投资者周二港股通净买入额创四年来最高
金融界 · 02-18
中国内地投资者周二港股通净买入额创四年来最高
康诺亚-B02月18日主力资金流入137万元 连续7日加仓
市场透视 · 02-18
康诺亚-B02月18日主力资金流入137万元 连续7日加仓
康诺亚-B02月14日主力资金流入975万元 连续5日加仓
市场透视 · 02-14
康诺亚-B02月14日主力资金流入975万元 连续5日加仓
康诺亚-B(02162)上涨5.15%,报34.7元/股
金融界 · 02-14
康诺亚-B(02162)上涨5.15%,报34.7元/股
康诺亚-B盘中异动 快速上涨5.15%报34.700港元
市场透视 · 02-14
康诺亚-B盘中异动 快速上涨5.15%报34.700港元
康诺亚-B02月12日获主力加仓148万元
市场透视 · 02-12
康诺亚-B02月12日获主力加仓148万元
【券商聚焦】国信证券维持康诺亚(02162)“优于大市”评级 指司普奇拜单抗有望占据先发优势
金吾财讯 · 02-10
【券商聚焦】国信证券维持康诺亚(02162)“优于大市”评级 指司普奇拜单抗有望占据先发优势
港股异动 | 康诺亚(02162)涨超4% 季节性过敏性鼻炎IL-4Rα生物制剂司普奇拜单抗获批上市
智通财经 · 02-10
港股异动 | 康诺亚(02162)涨超4% 季节性过敏性鼻炎IL-4Rα生物制剂司普奇拜单抗获批上市
康诺亚-B盘中异动 早盘股价大涨5.22%报33.250港元
市场透视 · 02-10
康诺亚-B盘中异动 早盘股价大涨5.22%报33.250港元
康诺亚-B:医药生物/生物制品公司研报
开源证券 · 02-09
康诺亚-B:医药生物/生物制品公司研报
【港股通】康诺亚(02162)司普奇拜单抗新适应症上市申请获药监局批准
金吾财讯 · 02-07
【港股通】康诺亚(02162)司普奇拜单抗新适应症上市申请获药监局批准
加载更多
公司概况
公司名称:
康诺亚-B
所属市场:
SEHK
上市日期:
--
主营业务:
Keymed Biosciences Inc是一家中国生物科技公司。该公司专注于自主发现及开发创新生物疗法以满足自体免疫及肿瘤治疗领域中未获满足的医疗需求。该公司已掌握内部药物发现及开发技术,其中包括构成其创新抗体发现平台及自有新型T细胞重定向(nTCE)双特异性抗体平台的技术。该公司还建立了涵盖生物药开发的关键功能的全面一体化平台。该公司主要产品包括CM310、CM326以及CMG901等。
发行价格:
--
{"stockData":{"symbol":"02162","market":"HK","secType":"STK","nameCN":"康诺亚-B","latestPrice":40.8,"timestamp":1744272498014,"preClose":38.7,"halted":0,"volume":1873500,"delay":0,"floatShares":279735566,"shares":279735566,"eps":-2.0889998584565244,"marketStatus":"已收盘","change":2.1,"latestTime":"04-10 16:08:18","open":39.2,"high":42,"low":39.2,"amount":77011175,"amplitude":0.072351,"askPrice":40.95,"askSize":500,"bidPrice":40.8,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-2.0889998584565244,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1744335000000},"marketStatusCode":5,"adr":0,"listingDate":1625673600000,"exchange":"SEHK","adjPreClose":38.7,"openAndCloseTimeList":[[1744248600000,1744257600000],[1744261200000,1744272000000]],"volumeRatio":0.443289,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02162","defaultTab":"news","newsList":[{"id":"2518210381","title":"康诺亚-B03月10日主力净流出652万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2518210381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518210381?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:15","pubTimestamp":1741594530,"startTime":"0","endTime":"0","summary":"03月10日, 康诺亚-B股价跌5.99%,报收34.50元,成交金额7173万元,换手率0.73%,振幅9.26%,量比1.45。康诺亚-B今日主力资金净流出652万元,上一交易日主力净流入136万元。该股近5个交易日下跌2.81%,主力资金累计净流出486万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流入4325万元,其中净流入天数为14日。该股主力净额占比0.07%,港股市场排名2539/2655。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310165722a269b8a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310165722a269b8a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1161","02162","BK1587"],"gpt_icon":0},{"id":"2518026116","title":"康诺亚-B盘中异动 下午盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518026116","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518026116?lang=zh_cn&edition=full","pubTime":"2025-03-10 13:18","pubTimestamp":1741583908,"startTime":"0","endTime":"0","summary":"2025年03月10日下午盘13时18分,康诺亚-B股票出现波动,股价快速跳水5.04%。截至发稿,该股报34.850港元/股,成交量109.81万股,换手率0.39%,振幅7.36%。资金方面,该股资金流入1315.68万港元,流出2046.87万港元。康诺亚-B股票所在的生物技术行业中,整体跌幅为2.61%。其相关个股中,同源康医药-B、和铂医药-B、永泰生物-B涨幅较大,振幅较大的相关个股有同源康医药-B、来凯医药-B、科笛-B,振幅分别为35.78%、20.08%、19.70%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310131829963fb78b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310131829963fb78b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1161","02162","BK1587"],"gpt_icon":0},{"id":"2517593109","title":"康诺亚-B03月07日主力净流入136万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517593109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517593109?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:15","pubTimestamp":1741335333,"startTime":"0","endTime":"0","summary":"03月07日,康诺亚-B股价收平报36.70元,成交金额5635万元,换手率0.55%,振幅5.31%,量比1.00。康诺亚-B今日主力资金净流入136万元,上一交易日主力净流出480万元。该股近5个交易日上涨5.53%,主力资金累计净流入117万元;近20日主力资金累计净流入5125万元,其中净流入天数为15日。该股主力净额占比0.01%,港股市场排名286/2653。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170010a263db9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170010a263db9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","BK1161","02162","BK1587"],"gpt_icon":0},{"id":"2516625102","title":"康诺亚-B03月04日主力净流入675万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2516625102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516625102?lang=zh_cn&edition=full","pubTime":"2025-03-04 17:38","pubTimestamp":1741081082,"startTime":"0","endTime":"0","summary":"03月04日, 康诺亚-B股价涨1.83%,报收36.20元,成交金额6048万元,换手率0.62%,振幅7.45%,量比0.78。康诺亚-B今日主力资金净流入675万元,上一交易日主力净流出49万元。该股近5个交易日上涨2.69%,主力资金累计净流入913万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入5473万元,其中净流入天数为15日。该股主力净额占比0.07%,港股市场排名65/2648。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304174025a25ea3da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304174025a25ea3da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02162","BK1587","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2514032369","title":"康诺亚-B盘中异动 急速跳水5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514032369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514032369?lang=zh_cn&edition=full","pubTime":"2025-02-28 09:55","pubTimestamp":1740707755,"startTime":"0","endTime":"0","summary":"2025年02月28日早盘09时55分,康诺亚-B股票出现异动,股价急速下跌5.10%。截至发稿,该股报35.350港元/股,成交量18.85万股,换手率0.07%,振幅5.50%。机构评级方面,在所有4家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。康诺亚-B股票所在的生物技术行业中,整体涨幅为1.44%。康诺亚-B公司简介:康诺亚生物医药科技有限公司是一家生物科技公司,专注于自主发现及开发自体免疫及肿瘤治疗领域的创新生物疗法的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228095556abe00caf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228095556abe00caf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1161","02162","BK1587"],"gpt_icon":0},{"id":"2514077465","title":"康诺亚-B盘中异动 下午盘股价大涨5.09%报37.150港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514077465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514077465?lang=zh_cn&edition=full","pubTime":"2025-02-26 13:20","pubTimestamp":1740547213,"startTime":"0","endTime":"0","summary":"2025年02月26日下午盘13时20分,康诺亚-B股票出现异动,股价急速上涨5.09%。截至发稿,该股报37.150港元/股,成交量110.95万股,换手率0.40%,振幅6.22%。资金方面,该股资金流入2271.14万港元,流出1136.87万港元。最近的财报数据显示,该股实现营业收入5,991.37万港元,净利润-3.69亿港元,每股收益-1.41港元,毛利5,582.02万港元,市盈率-26.21倍。康诺亚-B股票所在的生物技术行业中,整体涨幅为1.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226132013a2545cb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226132013a2545cb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02162","BK1574","BK1161","BK1587","BK1583"],"gpt_icon":0},{"id":"2514327030","title":"康诺亚-B盘中异动 股价大跌5.02%报35.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514327030","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514327030?lang=zh_cn&edition=full","pubTime":"2025-02-25 13:47","pubTimestamp":1740462449,"startTime":"0","endTime":"0","summary":"2025年02月25日下午盘13时47分,康诺亚-B股票出现波动,股价大幅跳水5.02%。截至发稿,该股报35.000港元/股,成交量151.65万股,换手率0.54%,振幅3.53%。资金方面,该股资金流入2553.57万港元,流出2049.47万港元。康诺亚-B股票所在的生物技术行业中,整体涨幅为1.60%。其相关个股中,加科思-B、基石药业-B、康希诺生物涨幅较大,振幅较大的相关个股有药明巨诺-B、加科思-B、康希诺生物,振幅分别为19.81%、18.65%、17.64%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502251347299891c2bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502251347299891c2bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1587","02162","BK1583","BK1161"],"gpt_icon":0},{"id":"2512274861","title":"康诺亚半年内四次NewCo出海,董事长称“非割青苗而是要培养茁壮”","url":"https://stock-news.laohu8.com/highlight/detail?id=2512274861","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512274861?lang=zh_cn&edition=full","pubTime":"2025-02-19 15:28","pubTimestamp":1739950104,"startTime":"0","endTime":"0","summary":"在中国创新药NewCo交易逐渐升温之际,总部位于成都的康诺亚(02162.HK),从去年7月份以来,这半年内,已干了四笔交易,其中的两笔,还是今年春节前完成的,这也使得公司在行业中出圈。NewCo模式的核心在于通过设立海外新公司,将创新药的海外权益授权给该新公司,并引入海外资本和国际化管理团队,从而实现产品出海。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502193323572742.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502193323572742.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02162","BK1574","BK1161","BK1583","BK1587"],"gpt_icon":0},{"id":"2512111961","title":"中国内地投资者周二港股通净买入额创四年来最高","url":"https://stock-news.laohu8.com/highlight/detail?id=2512111961","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512111961?lang=zh_cn&edition=full","pubTime":"2025-02-19 07:37","pubTimestamp":1739921873,"startTime":"0","endTime":"0","summary":"中国内地投资者周二通过港股通净买入224亿港元的香港股票,继续推动DeepSeek引发的科技股涨势。彭博数据显示,这是自2021年初以来最大单日净买入,也是有纪录以来第四高。恒生科技指数当日大涨2.5%,有望连续第六周上涨。内地资金大量涌入香港股市,已推动A股市场相较港股的溢价幅度缩小至约34%,这使得一项A-H股溢价指数接近在过去总会触发反弹的底部,引发了香港上市中资股跑赢内地股票的幅度可能缩小的担忧。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190739199627f2f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190739199627f2f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00257","03933","06821","00659","00293","01855","02380","09858","09626","01766","03311","06808","01929","02016","00777","00014","00003","03606","SG9999002463.SGD","03988","06690","01138","00384","00142","01066","02607","01585","01876","03328","00819","01541","01952","03918","00008","02099","02601","00412","01787","01919","00590","00576","00855","01888","00751","02498","02688","01963","06110","09992","02171","06855","09926","01024","00175","02269","02402","00853","02359","00512","01558","00013","06990","01921","01357","06818","00327","01199","01513","06160","02096","01810","02057","06616","00788","00152","02186","03969","02338","01860","09868","09923","02382","00836","03396","01177","00856","00189","02282","02333","03888","03800","00991","00288","01691","01052","09987","02015","01310","00317","01772","02367","01347","06127","03650","02618","00371","01112","06060","01675","06618","02005","01071","09899","00666","00177","00425","01530","02018","02121","03690","BK1589","09696","00981","02268","06680","00728","03968","00548","00267","02533","01789","00939","02162","00220","01735","03618","HSTECH","00300","00546","00772","09995","00467","01907","00148","HSCEI","09890","01579","BK1506","00241","02157","01818","01686","02158","02465","01211","06699","09988","02155","01070","01405","00867","00303","01618","09922","00392","06936","02172","06181","01341","00006","BK1133","01119","00107","09688","00144","03692","03360","09885","02400","01519","01658","00762","09969","06198","02883","00868","01093","00826","00270","01193","02208","01128","02105","00861","06186","09880","00005","BK1536","02600","00038","02386","00316","02291","06069","03369"],"gpt_icon":0},{"id":"2512135181","title":"康诺亚-B02月18日主力资金流入137万元 连续7日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2512135181","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512135181?lang=zh_cn&edition=full","pubTime":"2025-02-18 16:16","pubTimestamp":1739866614,"startTime":"0","endTime":"0","summary":"02月18日, 康诺亚-B股价涨1.29%,报收35.40元,成交金额7025万元,换手率0.71%,振幅5.15%,量比0.90。康诺亚-B今日主力资金净流入137万元,连续7日净流入,上一交易日主力净流入1610万元。该股近5个交易日上涨8.08%,主力资金累计净流入3906万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入3387万元,其中净流入天数为10日。该股主力净额占比0.01%,港股市场排名275/2650。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218161746abd34c5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218161746abd34c5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1587","02162","BK1583","BK1574"],"gpt_icon":0},{"id":"2511656707","title":"康诺亚-B02月14日主力资金流入975万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2511656707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511656707?lang=zh_cn&edition=full","pubTime":"2025-02-14 16:15","pubTimestamp":1739520922,"startTime":"0","endTime":"0","summary":"02月14日, 康诺亚-B股价涨5.61%,报收34.85元,成交金额6426万元,换手率0.67%,振幅6.67%,量比1.13。康诺亚-B今日主力资金净流入975万元,连续5日净流入,上一交易日主力净流入1035万元。该股近5个交易日上涨8.86%,主力资金累计净流入2329万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入1131万元,其中净流入天数为8日。该股主力净额占比0.10%,港股市场排名124/2650。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214161544abcea16f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214161544abcea16f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1587","02162","BK1583","BK1574"],"gpt_icon":0},{"id":"2511658389","title":"康诺亚-B(02162)上涨5.15%,报34.7元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2511658389","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511658389?lang=zh_cn&edition=full","pubTime":"2025-02-14 15:20","pubTimestamp":1739517605,"startTime":"0","endTime":"0","summary":"2月14日,康诺亚-B(02162)盘中上涨5.15%,截至15:20,报34.7元/股,成交4914.11万元。康诺亚生物医药科技有限公司专注于研发高质量、可负担的创新疗法,主要业务包括分子发现、工艺开发、转化医学、临床开发到商业化生产药品开发全周期。公司自主研发的一类创新药逾30项,其中9项已进入不同阶段临床研发,多项位于中国第一,世界前三,包含一项世界首创ADC新药,两项获得国家“十三五”“重大新药创制”科技重大专项支持。截至2024年中报,康诺亚-B营业总收入5468.2万元、净利润-3.37亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/14152048162288.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","02162","BK1161","BK1587","BK1583"],"gpt_icon":0},{"id":"2511630351","title":"康诺亚-B盘中异动 快速上涨5.15%报34.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511630351","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511630351?lang=zh_cn&edition=full","pubTime":"2025-02-14 15:19","pubTimestamp":1739517589,"startTime":"0","endTime":"0","summary":"2025年02月14日下午盘15时19分,康诺亚-B股票出现波动,股价快速拉升5.15%。截至发稿,该股报34.700港元/股,成交量143.3万股,换手率0.51%,振幅5.61%。资金方面,该股资金流入2706.66万港元,流出1652.51万港元。康诺亚-B股票所在的生物技术行业中,整体涨幅为3.48%。其相关个股中,维亚生物、诺诚健华、华领医药-B涨幅较大,振幅较大的相关个股有维亚生物、方达控股、美因基因,振幅分别为34.69%、18.24%、15.80%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502141519509622a2ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502141519509622a2ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","BK1161","02162","BK1587"],"gpt_icon":0},{"id":"2510342141","title":"康诺亚-B02月12日获主力加仓148万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510342141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510342141?lang=zh_cn&edition=full","pubTime":"2025-02-12 16:15","pubTimestamp":1739348155,"startTime":"0","endTime":"0","summary":"02月12日, 康诺亚-B股价跌0.91%,报收32.50元,成交金额6106万元,换手率0.67%,振幅3.66%,量比1.22。康诺亚-B今日主力资金净流入148万元,连续3日净流入,上一交易日主力净流入22万元。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为55.56%,平均涨幅为3.73%。该股近5个交易日上涨9.09%,主力资金累计净流入150万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出870万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212161617a242f285&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212161617a242f285&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","BK1583","02162","BK1161"],"gpt_icon":0},{"id":"2510003322","title":"【券商聚焦】国信证券维持康诺亚(02162)“优于大市”评级 指司普奇拜单抗有望占据先发优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2510003322","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510003322?lang=zh_cn&edition=full","pubTime":"2025-02-10 10:46","pubTimestamp":1739155560,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国信证券发研指,近日,康诺亚 的司普奇拜单抗治疗季节性过敏性鼻炎的新适应症获批上市,成为全球首个获批治疗季节性过敏性鼻炎的 IL4R 单抗。司普奇拜单抗进入关键的商业化验证期,差异化适应症的获批有望为其在商业化的早期带来一定的竞争优势。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/ODYzMTA4NTI1Nzg5MjIw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODYzMTA4NTI1Nzg5MjIw.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1952789","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162","002736"],"gpt_icon":0},{"id":"2510070836","title":"港股异动 | 康诺亚(02162)涨超4% 季节性过敏性鼻炎IL-4Rα生物制剂司普奇拜单抗获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2510070836","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510070836?lang=zh_cn&edition=full","pubTime":"2025-02-10 09:59","pubTimestamp":1739152761,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,康诺亚(02162)涨超4%,截至发稿,涨4.11%,报32.9港元,成交额842.94万港元。消息面上,2月7日,康诺亚宣布,公司自主研发的1类新药康悦达(司普奇拜单抗注射液)获国家药品监督管理局批准上市,用于治疗季节性过敏性鼻炎(SAR)。这是康悦达继2024年9月、12月批准用于治疗成人中重度特应性皮炎、慢性鼻窦炎伴鼻息肉之后获批的第三个适应症,成为目前全球首个获批治疗季节性过敏性鼻炎的IL-4Rα生物制剂,给患者提供突破性治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1247560.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02162","BK1574","BK1161","BK1583","BK1587"],"gpt_icon":0},{"id":"2510072787","title":"康诺亚-B盘中异动 早盘股价大涨5.22%报33.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510072787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510072787?lang=zh_cn&edition=full","pubTime":"2025-02-10 09:35","pubTimestamp":1739151307,"startTime":"0","endTime":"0","summary":"2025年02月10日早盘09时35分,康诺亚-B股票出现异动,股价急速拉升5.22%。截至发稿,该股报33.250港元/股,成交量8万股,换手率0.03%,振幅4.27%。资金方面,该股资金流入164.542万港元,流出38.725万港元。康诺亚-B股票所在的生物技术行业中,整体跌幅为0.29%。据统计,2024年7月至今,康诺亚四次通过Newco模式达成出海交易。今年1月10日,康诺亚宣布与Timberlyne达成独家授权许可协议,这成为2025年开年来生物医药行业里的第一单NewCo交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210093507abc8d6fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210093507abc8d6fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1587","02162","BK1574","BK1161"],"gpt_icon":0},{"id":"2510325518","title":"康诺亚-B:医药生物/生物制品公司研报","url":"https://stock-news.laohu8.com/highlight/detail?id=2510325518","media":"开源证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510325518?lang=zh_cn&edition=full","pubTime":"2025-02-10 00:00","pubTimestamp":1739116800,"startTime":"0","endTime":"0","summary":"根据13 个城市门诊患者临床特征调查显示,持续性中重度过敏性鼻炎患者占比达52.2%。司普奇拜单抗:全球首批用于季节性过敏性鼻炎治疗的生物制剂司普奇拜单抗是全球首个获批用于治疗经鼻用糖皮质激素联合抗组胺药物治疗后症状控制不佳的成人中重度季节性过敏性鼻炎的IL-4Rα 生物制剂,能够有效控制鼻部和眼部过敏症状,为季节性过敏性鼻炎治疗带来新的突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210181120a2405856&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210181120a2405856&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","02162","BK1161","BK1583","BK1574"],"gpt_icon":0},{"id":"2509779413","title":"【港股通】康诺亚(02162)司普奇拜单抗新适应症上市申请获药监局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2509779413","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509779413?lang=zh_cn&edition=full","pubTime":"2025-02-07 16:50","pubTimestamp":1738918246,"startTime":"0","endTime":"0","summary":"本次获批是基于一项多中心、随机、双盲、安慰剂平行对照的III期研究,主要用于确证司普奇拜单抗注射液治疗对鼻用糖皮质激素或其他治疗方法控制不佳的成人季节性过敏性鼻炎患者的有效性和安全性。与此同时,司普奇拜单抗还能有效缓解眼部过敏症状,全面提升患者生活质量,且安全性良好。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/YWMzMDYxNjliM2VjNmQwMDUwODkzNDE4MTMw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/YWMzMDYxNjliM2VjNmQwMDUwODkzNDE4MTMw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1952751","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSCEI","HSTECH","BK1161","BK1587","02162","YANG","BK1583","BK1574"],"gpt_icon":1}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1954},{"period":"1month","weight":0.1217},{"period":"3month","weight":0.3438},{"period":"6month","weight":-0.0797},{"period":"1year","weight":0.1853},{"period":"ytd","weight":0.2524}],"compareEarnings":[{"period":"1week","weight":-0.1266},{"period":"1month","weight":-0.148},{"period":"3month","weight":0.0532},{"period":"6month","weight":-0.0465},{"period":"1year","weight":0.2042},{"period":"ytd","weight":0.0102}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Keymed Biosciences Inc是一家中国生物科技公司。该公司专注于自主发现及开发创新生物疗法以满足自体免疫及肿瘤治疗领域中未获满足的医疗需求。该公司已掌握内部药物发现及开发技术,其中包括构成其创新抗体发现平台及自有新型T细胞重定向(nTCE)双特异性抗体平台的技术。该公司还建立了涵盖生物药开发的关键功能的全面一体化平台。该公司主要产品包括CM310、CM326以及CMG901等。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.087989},{"month":2,"riseRate":0.75,"avgChangeRate":0.088362},{"month":3,"riseRate":0.25,"avgChangeRate":-0.018584},{"month":4,"riseRate":0.75,"avgChangeRate":0.004415},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.125967},{"month":6,"riseRate":1,"avgChangeRate":0.150041},{"month":7,"riseRate":0.333333,"avgChangeRate":0.066538},{"month":8,"riseRate":0.5,"avgChangeRate":0.01599},{"month":9,"riseRate":0.75,"avgChangeRate":0.035232},{"month":10,"riseRate":0.5,"avgChangeRate":0.051059},{"month":11,"riseRate":0.5,"avgChangeRate":0.048399},{"month":12,"riseRate":0.25,"avgChangeRate":-0.145383}],"exchange":"SEHK","name":"康诺亚-B","nameEN":"KEYMED BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.2","shortVersion":"4.32.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康诺亚-B(02162)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康诺亚-B(02162)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康诺亚-B,02162,康诺亚-B股票,康诺亚-B股票老虎,康诺亚-B股票老虎国际,康诺亚-B行情,康诺亚-B股票行情,康诺亚-B股价,康诺亚-B股市,康诺亚-B股票价格,康诺亚-B股票交易,康诺亚-B股票购买,康诺亚-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康诺亚-B(02162)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康诺亚-B(02162)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}